A comprehensive view of Moderna Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Bioeconomy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Moderna to make job cuts in manufacturing unit due to resized COVID-19 production work; company to focus on growing other production areas, including recently acquired Marlborough facility for neoantigen therapy production

Moderna to host fifth annual investor event for vaccines and business updates on March 27, 2024

Laboratorios Farmacéuticos Rovi in Spain gains FDA approval for producing Moderna's COVID-19 Spikevax vaccine at its Granada plant for US market; CEO Juan López-Belmonte sees future CDMO services growth and expects higher demand for Spikevax

Moderna to Present at Upcoming Investor Conferences in March 2024

Moderna concludes construction of respiratory mRNA vaccine manufacturing facility in Laval, Quebec, with operations set to begin by 2025; the initiative is part of a partnership with the Canadian government and is partly funded by Quebec

Ask us about our Bioeconomy market view

Trending Chart

Interactive chart with headline count